Affiliations: [a] College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates
| [b] Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates
| [c] School of Medicine, Faculty of Health, Deakin University, Geelong, Australia
| [d] Family and Community Medicine & Behavioral Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates
| [e] Department of Clinical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman, United Arab Emirates
Correspondence:
[*]
Correspondence to: Hamzah Alzubaidi, BPharm (Hons), MPharm (Clinic), PhD, College of Pharmacy, University
of Sharjah, PO Box 27272, Sharjah, United Arab Emirates. Tel.: +971 6 505
7424; E-mail: [email protected].
Abstract: Background:The global prevalence of Alzheimer’s disease (AD) and its treatment costs are projected to increase significantly, placing increasing pressure on health systems to create new models of care. Community pharmacists are well-positioned to provide medication management for people with AD. In Arabic-speaking countries, little is known about pharmacists’ knowledge and practices in caring for people with AD. Objective:To evaluate community pharmacists’ knowledge of AD and its management, counseling skills, and dispensing patterns when caring for people with AD and their caregivers in the United Arab Emirates (UAE). Methods:A large-scale cross-sectional survey of community pharmacists was conducted in three cities in the UAE using stratified random sampling. The questionnaire comprised of validated tools to measure knowledge and open-ended questions. A logistic regression model was conducted to predict counseling comprehensiveness. Results:A total of 325 community pharmacists completed the questionnaire. The mean knowledge scores about AD and its pharmacotherapy were 57.0% and 67.6%, respectively. Major shortcomings in pharmacists’ practices were identified; history-taking, adherence assessment, and counseling were provided by 2.2%, 9.3%, and 17.3%, respectively. A minority provided comprehensive counselling; the multivariate analysis yielded new insights into pharmacist characteristics associated with such counseling. Conclusion:Pharmacists did not provide structured patient-centered care for people with AD. Community pharmacists did not provide adequate counseling, did not assess adherence-related issues appropriately, and had deficient knowledge. To develop patient-centered pharmacy-based services for Arabic-speaking communities, a multifaceted approach is required that goes beyond improving pharmacy workforce knowledge and communication skills to address broader sociocultural, legislative, and financial factors.
